ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,168Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 278

$1.7M Total Retail Price of All Prescriptions

Rank: 4 out of 278

976 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 976 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 976 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 24,038 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,395 938 S3 1 1
FUROSEMIDE 842 730 2 6
SIMVASTATIN 777 651 3 4
LISINOPRIL 697 613 4 5
LEVOTHYROXINE SODIUM 648 630 5 2
OMEPRAZOLE 637 544 6 3
METOPROLOL TARTRATE 623 532 7 9
AMLODIPINE BESYLATE 603 574 8 7
WARFARIN SODIUM 524 461 9 11
POTASSIUM CHLORIDE 484 429 10 17
GABAPENTIN 429 360 11 12
CARVEDILOL 411 362 12 23
TAMSULOSIN HCL 400 332 13 32
DONEPEZIL HCL 395 395 14 29
METOPROLOL SUCCINATE 372 345 15 10
METFORMIN HCL 341 263 16 8
TRAMADOL HCL 328 283 17 22
CLOPIDOGREL 299 269 18 20
FENOFIBRATE 292 232 19 64
PANTOPRAZOLE SODIUM 277 240 20 36
NEXIUM 268 228 21 14
CEFUROXIME 266 224 22 86
PREDNISONE 252 223 23 35
CYMBALTA 246 208 24 41
SERTRALINE HCL 244 223 25 25
NAMENDA 226 226 26 48
CITALOPRAM HBR 223 180 27 21
FENTANYL 213 211 S2 28 82
TRAZODONE HCL 211 196 29 47
ATORVASTATIN CALCIUM 211 179 29 13
PLAVIX 208 193 31 30
ATENOLOL 208 188 31 18
LANTUS 205 177 33 56
HYDROCHLOROTHIAZIDE 201 179 34 15
ESCITALOPRAM OXALATE 201 182 34 63
LOSARTAN POTASSIUM 201 157 34 24
MIRTAZAPINE 199 190 37 61
AZITHROMYCIN 197 169 38 39
GLIMEPIRIDE 191 162 39 28
OLANZAPINE 189 158 40 142
BYSTOLIC 188 151 41 114
TORSEMIDE 177 165 42 97
DIGOXIN 176 158 43 40
CRESTOR 170 125 44 19
POLYETHYLENE GLYCOL 3350 166 156 45 74
ISOSORBIDE MONONITRATE ER 159 149 46 33
ROPINIROLE HCL 147 130 47 69
LEVETIRACETAM 139 97 48 106
ALLOPURINOL 139 137 48 38
SPIRONOLACTONE 137 102 50 62
RISPERIDONE 135 114 51 79
JANUVIA 135 112 51 53
CLONIDINE HCL 130 117 53 50
ZOLPIDEM TARTRATE 130 88 53 26
PAROXETINE HCL 128 126 55 57
OXYCODONE-ACETAMINOPHEN 127 96 S2 56 71
GLIPIZIDE 127 114 56 55
ADVAIR DISKUS 126 110 58 45
LIDODERM 123 115 59 215
DIOVAN 123 117 59 43
BENAZEPRIL HCL 123 93 59 108
DIVALPROEX SODIUM 120 84 62 103
PRAVASTATIN SODIUM 120 117 62 16
COMBIVENT 118 91 64 117
LOVAZA 116 111 65 102
NITROGLYCERIN PATCH 114 99 66 125
MECLIZINE HCL 114 106 66 111
FLUTICASONE PROPIONATE 113 88 68 44
SPIRIVA 113 90 68 49
PROAIR HFA 112 94 70 34
THEOPHYLLINE ANHYDROUS 112 98 70 136
AMITRIPTYLINE HCL 110 99 R 72 73
KLOR-CON M20 109 92 73 42
RANITIDINE HCL 107 96 74 27
TRICOR 103 75 75 87
FELODIPINE ER 99 88 76 112
SINGULAIR 98 78 77 60
LACTULOSE 97 53 78 155
CIPROFLOXACIN HCL 96 80 79 65
ONGLYZA 92 75 80 161
VENLAFAXINE HCL ER 90 85 81 126
LEVEMIR 88 88 82 183
SYMBICORT 84 64 83 109
TRILIPIX 83 63 84 196
LEVOFLOXACIN 82 66 85 66
TRIAMTERENE-HCTZ 79 79 86 58
JANUMET 77 64 87 170
HYDRALAZINE HCL 76 54 88 91
OXYBUTYNIN CHLORIDE ER 76 66 88 146
ALENDRONATE SODIUM 75 63 90 51
INSULIN SYRINGE 75 50 90 72
ALBUTEROL SULFATE 75 72 90 141
PRADAXA 75 64 90 166
PHENYTOIN SODIUM EXTENDED 74 47 94 135
WELCHOL 71 63 95 182
ACETAMINOPHEN-CODEINE 69 57 S3 96 144
SILVER SULFADIAZINE 69 69 96 305
LEXAPRO 69 64 96 203
QUETIAPINE FUMARATE 67 58 99 80
IPRATROPIUM BROMIDE 65 65 100 197
NOVOLOG 65 44 100 122
ALPRAZOLAM 64 47 102 128
BACLOFEN 64 14 102 172
AMLODIPINE BESYLATE-BENAZEPRIL 59 48 104 77
FINASTERIDE 58 46 105 104
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 54 105 98
DILTIAZEM 24HR CD 55 55 107 95
NAPROXEN 55 49 107 115
LOVASTATIN 53 52 109 52
FLUOXETINE HCL 53 46 109 68
AMOX TR-POTASSIUM CLAVULANATE 53 44 109 129
HUMALOG 53 47 109 173
PRANDIN 52 38 113 348
RISPERDAL CONSTA 52 52 113 287
IBUPROFEN 51 41 115 89
CILOSTAZOL 51 49 115 200
XARELTO 50 45 117 355
IPRATROPIUM-ALBUTEROL 50 50 117 193
ENALAPRIL MALEATE 50 38 117 70
RAMIPRIL 50 50 117 81
PEN NEEDLE 50 38 117 105
GENERLAC 50 33 117 280
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.